부산대학교 도서관

Cancer. 97:3131-3131

Yang H; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Arita K; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bowman K; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; University of Texas MD Ander Cancer Center UT Health Houston Graduate School of Biological Sciences, Houston, TX, USA.; Chihara D; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Henderson J; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rost G; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rojas E; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Parsons S; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lakra P; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Abedin A; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Neelapu SS; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Strati P; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nastoupil LJ; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fayad L; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Iyer SP; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rodriguez A; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hagemeister FB; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Malpica L; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee HJ; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hilton L; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Scott DW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Davis RE; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Flowers CR; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Westin JR; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Inghirami G; Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY 10065, USA.; Vega F; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Green MR; Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Cabanillas F; Centro de Cancer Auxilio Mutuo, San Juan, Puerto Rico; Section of Hematology and Medical Oncology, Department of Medicine, University of Puerto Rico School of Medicine, San Juan, Puerto Rico. Electronic address: cabanillasmd@gmail.com.; Conde JG; Division of Graduate Studies University of Puerto Rico School of Medicine, San Juan, Puerto Rico.; Gutierrez T; Section of Hematology and Medical Oncology, Department of Medicine, University of Puerto Rico School of Medicine, San Juan, Puerto Rico.; Torres A; Centro de Cancer Auxilio Mutuo, San Juan, Puerto Rico.; Abreu J; Centro de Cancer Auxilio Mutuo, San Juan, Puerto Rico.; Hagemeister FB; University of Texas MD Anderson Cancer Center, Houston, TX.

Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Akkad N; Division of Cancer Medicine, Hematology/Medical Oncology Fellowship Program, The University of Texas MD Anderson Cancer Center, Houston, TX.; Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.; Westin JR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Hagemeister FB; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Lee HJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Fayad L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Ahmed S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Nair R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Rodriguez MA; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Strati P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Chihara D; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Flowers CR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Claret L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Ibanez K; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Fowler NH; BostonGene, Waltham, MA.; Henderson J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Davis RE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Green M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Gordon MJ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Strati P; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Lee HJ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Hagemeister FB; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Westin JR; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Samaniego F; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Marques-Piubelli ML; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Vega Vazquez F; Division of Pathology and Laboratory Medicine, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Parra Cuentas ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Solis-Soto LM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ma W; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Wang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Claret L; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Averill B; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ibanez K; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Fayad LE; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Flowers CR; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Green MR; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Davis RE; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Neelapu SS; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Fowler NH; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Nastoupil LJ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Chihara D; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Steiner RE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Nair R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.; Ahmed S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Strati P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Malpica L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Griffith DP; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Mathew SA; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Montinez W; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Masand G; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Samaniego F; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Rodriguez MA; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Hagemeister FB; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Fayad LE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Iyer SP; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Flowers CR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Westin JR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Gurumurthi A; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Chin CK; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Haematology, Royal Perth Hospital, Perth, WA, Australia.; University of Western Australia, Perth, WA, Australia.; Feng L; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fowler NH; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; BostonGene, Waltham, MA, USA.; Strati P; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hagemeister FB; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fayad LE; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Westin JR; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Obi C; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Arafat J; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nair R; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Steiner RE; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Neelapu SS; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Flowers CR; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nastoupil LJ; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE

Biomedicine & Pharmacotherapy. 50(9):433-441

Albitar M; Genomic Testing Cooperative, LCA, Irvine, CA, 92618, USA. malbitar@genomictestingcooperative.com.; Zhang H; Genomic Testing Cooperative, LCA, Irvine, CA, 92618, USA.; Goy A; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ, 07601, USA.; Xu-Monette ZY; Duke University Medical Center, Durham, NC, 27710, USA.; Bhagat G; Columbia University Medical Center, New York, NY, 10027, USA.; Visco C; University of Verona, 37129, Verona, Italy.; Tzankov A; Institute of Pathology, University Hospital Basel, 4054, Basel, Switzerland.; Fang X; Duke University Medical Center, Durham, NC, 27710, USA.; Zhu F; Duke University Medical Center, Durham, NC, 27710, USA.; Dybkaer K; Aalborg University Hospital, Aalborg, 5000-5270, Denmark.; Chiu A; Mayo Clinic, Rochester, MN, 55905, USA.; Tam W; Weill Medical College of Cornell University, New York, NY, 10065, USA.; Zu Y; The Methodist Hospital, Houston, TX, 77030, USA.; Hsi ED; Wake Forest University Medical Center, Winston-Salem, NC, 77055, USA.; Hagemeister FB; The University of Texas MD Anderson Cancer Center, Houston, TX, 22030, USA.; Huh J; Asan Medical Center, Ulsan University College of Medicine, Seoul, 05505, Korea.; Ponzoni M; San Raffaele H. Scientific Institute, 20132, Milan, Italy.; Ferreri AJM; San Raffaele H. Scientific Institute, 20132, Milan, Italy.; Møller MB; Odense University Hospital, Odense, 5000-5270, Denmark.; Parsons BM; Gundersen Lutheran Health System, La Crosse, WI, 54601, USA.; van Krieken JH; Radboud University Nijmegen Medical Centre, 6500, Nijmegen, Netherlands.; Piris MA; Hospital Universitario Marqués de Valdecilla, 39008, Santander, Spain.; Winter JN; Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.; Li Y; Baylor College of Medicine, Houston, TX, 77030, USA.; Xu B; The First Affiliated Hospital of Xiamen University, 361004, Xiamen, Fujian, China. xubingzhangjian@126.com.; Young KH; Duke University Medical Center, Durham, NC, 27710, USA. ken.young@duke.edu.; Duke Cancer Institute, Durham, NC, 27710, USA. ken.young@duke.edu.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

You H; Department of Hematology and Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carollina, USA.; Xu-Monette ZY; Department of Hematology and Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.; Wei L; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carollina, USA.; Duke Cancer Institute, Durham, North Caronlina, USA.; Nunns H; Duke Cancer Institute, Durham, North Caronlina, USA.; Nagy ML; Duke Cancer Institute, Durham, North Caronlina, USA.; Bhagat G; NeoGenomics Laboratories, Aliso Viejo, California, USA.; Fang X; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carollina, USA.; Zhu F; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carollina, USA.; Visco C; Department of Pathology and Cell Biology, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, New York, USA.; Tzankov A; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.; Dybkaer K; Department of Pathology, Institute of Pathology,University Hospital Basel, Switzerland.; Chiu A; Clinical Department, Aalborg University Hospital, Aalborg, Denmark.; Tam W; Hematopathology Department, Mayo Clinic, Rochester, Minnesota, USA.; Zu Y; Department of Pathology, Weill Medical College of Cornell University, New York, New York, USA.; Hsi ED; Department of Pathology and Genomic Medicine, The Methodist Hospital, Houston, Texas, USA.; Hagemeister FB; Department of Pathology, Cleveland Clinic, Cleveland, Ohio, USA.; Huh J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ponzoni M; Department of Pathology, Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea.; Ferreri AJM; Department of Pathology, Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea.; Møller MB; Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Parsons BM; Department of Pathology, Odense University Hospital, Odense, Denmark.; Van Krieken JH; Hematology & Oncology, Gundersen Lutheran Health System, La Crosse, Wisconsin, USA.; Piris MA; Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands.; Winter JN; Pathology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain.; Li Y; Department of Medicine (Hematology and Oncology), Feinberg School of Medicine, Northwestern University, Chicago, Illinois,USA.; Au Q; Duke Cancer Institute, Durham, North Caronlina, USA.; Xu B; Department of Medicine, Baylor College of Medicine, Houston, Texas,USA.; Albitar M; Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian,China.; Young KH; Department of Hematology and Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.; Genomic Testing Cooperative, LCA, Irvine, California,USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

Samaniego F; The University of Texas MD Anderson Cancer Center, Houston, Texas.; McLaughlin P; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Neelapu SS; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Feng L; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Fanale M; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Nastoupil L; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Rodriguez MA; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Pro B; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Taylor E; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Hagemeister FB; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Fowler N; The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Xu-Monette ZY; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carolina.; Li Y; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Snyder T; Adaptive Biotechnologies, Seattle, Washington.; Yu T; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carolina.; Lu T; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carolina.; Tzankov A; Institute of Pathology, University Hospital Basel, Basel, Switzerland.; Visco C; Department of Hematology, University of Verona, Verona, Italy.; Bhagat G; Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, New York.; Qian W; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.; Dybkaer K; Aalborg University Hospital, Aalborg, Denmark.; Chiu A; Mayo Clinic, Rochester, Minnesota.; Tam W; Weill Medical College of Cornell University, New York, New York.; Zu Y; The Methodist Hospital, Houston, Texas.; Hsi ED; Wake Forest University, Winston-Salem, North Carolina.; Hagemeister FB; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wang Y; The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Go H; Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea.; Ponzoni M; San Raffaele H. Scientific Institute, Milan, Italy.; Ferreri AJM; San Raffaele H. Scientific Institute, Milan, Italy.; Møller MB; Odense University Hospital, Odense, Denmark.; Parsons BM; Gundersen Lutheran Health System, La Crosse, Wisconsin.; Fan X; Pathology Center, Anhui Medical University and the first Affiliated Hospital, Hefei, China.; van Krieken JH; Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.; Piris MA; Hospital Universitario Marqués de Valdecilla, Santander, Spain.; Winter JN; Feinberg School of Medicine, Northwestern University, Chicago, Illinois.; Au Q; NeoGenomics Laboratories, Aliso Viejo, California.; Kirsch I; Adaptive Biotechnologies, Seattle, Washington.; Zhang M; The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Shaughnessy J; Myeloma Center, Winthrop P. Rockefeller Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas.; Xu B; The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.; Young KH; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, North Carolina.; Duke Cancer Institute, Durham, North Carolina.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Chin CK; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rodriguez MA; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Qing Y; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Feng L; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Samaniego F; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jain P; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Noorani M; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fowler NH; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fayad LE; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Westin JR; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Neelapu SS; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hagemeister FB; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Flowers CR; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nastoupil LJ; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Chin CK; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Lim KJ; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Lewis K; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia.; Medical School, University of Western Australia, Nedlands, Australia.; Jain P; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Qing Y; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Feng L; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cheah CY; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia.; Medical School, University of Western Australia, Nedlands, Australia.; Seymour JF; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; The University of Melbourne, Melbourne, Australia.; Ritchie D; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; The University of Melbourne, Melbourne, Australia.; Burbury K; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Tam CS; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; The University of Melbourne, Melbourne, Australia.; St Vincent's Hospital Melbourne, Melbourne, Australia.; Fowler NH; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fayad LE; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Westin JR; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Neelapu SS; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hagemeister FB; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Samaniego F; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Flowers CR; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nastoupil LJ; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Dickinson MJ; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; The University of Melbourne, Melbourne, Australia.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

King, KM; Wood, AM; Arbuckle, RB; Adamus, AT; Hagemeister, FB

Value in Health. 5(3):194-195

Strati P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ahmed MA; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hagemeister FB; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fayad LE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rodriguez MA; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Samaniego F; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Westin JR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee HJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Iyer SP; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Parmar S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ahmed S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nair R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Steiner RE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Noorani M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Flowers CR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Davis RE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fowler NH; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Gastroenterology. 108(4):A541-A541

Zhou H; Duke University Medical Center, Division of Hematopathology and Department of Pathology, Durham, NC, USA.; Xu-Monette ZY; Duke University Medical Center, Division of Hematopathology and Department of Pathology, Durham, NC, USA.; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Xiao L; Department of Histology and Embryology, School of Basic Medical Science, Central South University, Changsha, Hunan, China.; Strati P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hagemeister FB; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; He Y; Department of Lymphoma and Hematology, the Affiliated Tumor Hospital of Xiangya Medical School of Central South University, Changsha, Hunan, China.; Chen H; Department of Lymphoma and Hematology, the Affiliated Tumor Hospital of Xiangya Medical School of Central South University, Changsha, Hunan, China.; Li Y; Department of Lymphoma and Hematology, the Affiliated Tumor Hospital of Xiangya Medical School of Central South University, Changsha, Hunan, China.; Manyam GC; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Li Y; Department of Medicine, Baylor College of Medicine, Houston, TX, USA.; Montes-Moreno S; Servicio de Anatomía Patológica, Translational Hematopathology Lab, Hospital Universitario Marqués de Valdecilla/IDIVAL, Santander, Spain.; Piris MA; Fundacion Jimenez Diaz; CIBERONC, Madrid, Spain.; Young KH; Duke University Medical Center, Division of Hematopathology and Department of Pathology, Durham, NC, USA. ken.young@duke.edu.; Duke Cancer Institute, Durham, NC, USA. ken.young@duke.edu.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Strati P; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Li X; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Deng Q; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Marques-Piubelli ML; Department Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Henderson J; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Watson G; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Deaton L; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cain T; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yang H; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ravanmehr V; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fayad LE; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Iyer SP; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nastoupil LJ; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hagemeister FB; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Parra ER; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Saini N; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Takahashi K; Department Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fowler NH; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Westin JR; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Steiner RE; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nair R; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Flowers CR; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ahmed S; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Al-Atrash G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Vega F; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Neelapu SS; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: sneelapu@mdanderson.org.; Green MR; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: mgreen5@mdanderson.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

SEYMOUR, JF; HAGEMEISTER, FB; DIMOPOULOS, M; CABANILLAS, F